Picture of Valneva SE logo

VLA — Valneva SE News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Brief: EMA's PRAC Lifts Temporary Restriction On Ixchiq Vaccination For People 65 Years & Older

July 11 (Reuters) - EMA:

EMA CONCLUDES REVIEW OF SEMAGLUTIDE MEDICINES AND STARTS REVIEW OF TWO CHICKENPOX VACCINES

IXCHIQ TEMPORARY RESTRICTION ON VACCINATING PEOPLE 65 YEARS AND OLDER TO BE LIFTED

PRAC CONCLUDED IXCHIQ SHOULD ONLY BE GIVEN WHEN THERE IS A SIGNIFICANT RISK OF CHIKUNGUNYA INFECTION & AFTER CONSIDERATION OF BENEFITS & RISKS

PRAC RECOMMENDED UPDATE TO PRODUCT INFORMATION OF VARILRIX AND VARIVAX TO FURTHER DESCRIBE SEVERITY OF RISK OF ENCEPHALITIS

AMENDED PRODUCT INFORMATION OF CHICKENPOX VACCINES WILL GIVE FURTHER DETAIL ON THE KNOWN SIDE EFFECT ENCEPHALITIS

PRAC ASSESSING NEW DATA ON POTENTIAL RISK OF NEURODEVELOPMENTAL DISORDERS IN CHILDREN BORN TO MEN TREATED WITH VALPROATE

Further company coverage: VLS.PA

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Valneva SE

See all news